Hyperreflective dots: A new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration

Ophthalmologica

Volumn 229, Issue 1, 2012, Pages 32-37

  Coscas, Gabriel ^a,b   De Benedetto, Umberto ^a   Coscas, Florence ^a,b   Li Calzi, Concetta I ^b   Vismara, Sabrina ^a   Roudot Thoraval, Françoise ^b   Bandello, Francesco ^c   Souied, Eric ^b  

^a Centre d'Ophtalmologie   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Anti vascular endothelial growth factor treatment; Exudative age related macular degeneration; Hyperreflective dots; Spectral domain optical coherence tomography

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSPECTIVE STUDY; RETINA; RETINA MACULA AGE RELATED DEGENERATION; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULA LUTEA; MALE; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84871610099     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000342159     Document Type: Article

References (23)

1. Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi CI: Clinical features and natural history of AMD; in Coscas G, Coscas F, Visma-ra S, Zourdani A, Li Calzi CI (eds): Optical Coherence Tomography in Age-Related Macular Degeneration. Heidelberg, Springer, 2009, pp 171-174.
2. Akagi-Kurashige Y, Tsujikawa A, Oishi A, Ooto S, Yamashiro K, Tamura H, Nakata I, Ueda-Arakawa N, Yoshimura N: Relationship between retinal morphological findings and visual function in age-related macular degeneration. Graefes Arch Clin Exp Oph-thalmol 2012, E-pub ahead of print.
3. Yannuzzi LA, Friedman R, Fine SL, Gass JDM, Gitter KA, Orth DH, Singerman LJ: Symposium on age-related macular degeneration. Bull NY Acad Med 1988; 64: 955-1013.
4. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY: Ranibizu-mab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419-1431.
5. Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd, Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group: Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 2012; 119: 1388-1398.
6. Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Wordsworth S, Reeves BC, The IVAN Study Investigators: Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology 2012; 119: 1399-1411.
7. Coscas G, Coscas F, Vismara S, Souied E, Soubrane G: Spectral domain OCT in age-related macular degeneration: preliminary results with Spectralis HRA-OCT. J Fr Oph-thalmol 2008; 31: 353-361.
8. Witkin AJ, Vuong LN, Srinivasan VJ, Gorc-zynska I, Reichel E, Baumal CR, Rogers AH, Schuman JS, Fujimoto JG, Duker JS: Highspeed ultrahigh resolution optical coherence tomography before and after ranibizumab for age-related macular degeneration. Ophthalmology 2009; 116:956-963.
9. Wolf-Schnurrbusch UE, Enzmann V, Brinkmann CK, Wolf S: Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Invest Ophthalmol Vis Sci 2008; 49: 3095-3099.
10. Framme C, Panagakis G, Birngruber R: Effects on choroidal neovascularization after anti-VEGF upload using intravitreal ranibi-zumab, as determined by spectral domain-optical coherence tomography. Invest Ophthalmol Vis Sci 2010; 51: 1671-1676.
11. Coscas G, Loewenstein A, Augustin A, Ban-dello F, Battaglia Parodi M, Lanzetta P, Monés J, de Smet M, Soubrane G, Staurenghi G: Management of retinal vein occlusion-consensus document. Ophthalmologica 2011; 226: 4-28.
12. Ogino K, Murakami T, Tsujikawa A, Miyamoto K, Sakamoto A, Ota M, Yoshimura N: Characteristics of optical coherence tomographic hyperreflective foci in retinal vein occlusion. Retina 2012; 32:77-78.
13. Bolz M, Schmidt-Erfurth U, Deak G, Mylo-nas G, Kriechbaum K, Scholda C: Optical coherence tomographic hyper-reflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology 2009; 116:914-920.
14. Omri S, Behar-Cohen F, de Kozak Y, Sennlaub F, Verissimo LM, Jonet L, Savoldelli M, Omri B, Crisanti P: Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCÇ in the Goto Kakizaki rat model. Am J Pathol 2011; 179:942-953.
15. Ota M, Nishijima K, Sakamoto A, Murakami T, Takayama K, Horii T, Yoshimura N: Optical coherence tomographic evaluation of fo-veal hard exudates in patients with diabetic maculopathy accompanying macular detachment. Ophthalmology 2010; 117: 1996-2002.
16. Horii T, Murakami T, Nishijima K, Akagi T, Uji A, Arakawa N, Muraoka Y, Yoshimura N: Relationship between fluorescein pooling and optical coherence tomographic reflectivity of cystoid spaces in diabetic macu-lar edema. Ophthalmology 2012; 119:1047-1055.
17. Fong AH, Li KK, Wong D: Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease. Retina 2011; 31: 502-509.
18. Marmor MF: Mechanisms of fluid accumulation in retinal edema. Doc Ophthalmol 1999; 97: 239-249.
19. Zarbin MA: Current concepts in the patho-genesis of age-related macular degeneration. Arch Ophthalmol 2004; 122: 598-614.
20. Augustin AJ, Kirchhof J: Inflammation and the pathogenesis of age-related macular degeneration. Expert Opin Ther Targets 2009; 13: 641-651.
21. Ma W, Zhao L, Wong WT: Microglia in the outer retina and their relevance to pathogen-esis of age-related macular degeneration. Adv E xp Med Biol 2012; 723: 37-42.
22. Xu H, Chen M, Forrester JV: Para-inflammation in the aging retina. Prog Retin Eye Res 2009; 28: 348-368.
23. Provis JM, Diaz CM, Penfold PL: Microglia in human retina: a heterogeneous population with distinct ontogenies. Perspect Dev Neurobiol 1996; 3:213-222.